Jason Wang1, Ronald Ma2, Leonid Churilov3, Paul Eleftheriou4, Mehrdad Nikfarjam5, Christopher Christophi5, Laurence Weinberg6. 1. Department of Anaesthesia, Austin Hospital, Heidelberg, VIC 3084, Australia. 2. Department of Finance, Austin Hospital, Heidelberg, VIC 3084, Australia. 3. The Florey Institute of Neuroscience & Mental Health, Parkville, VIC 3052, Australia. 4. Deputy Chief Medical Office, Austin Hospital, Heidelberg, VIC 3084, Australia. 5. University of Melbourne, Department of Surgery, Austin Hospital, Heidelberg, VIC 3084, Australia. 6. Department of Anaesthesia, Austin Hospital, Heidelberg, VIC 3084, Australia; University of Melbourne, Department of Surgery, Austin Hospital, Heidelberg, VIC 3084, Australia. Electronic address: laurence.weinberg@austin.org.au.
Abstract
BACKGROUND/ OBJECTIVES: Pancreaticoduodenectomy (PD), also known as a Whipple procedure, is commonly performed for a variety of benign and malignant tumours, including of the pancreatic head and surrounding structures. PD is associated with low mortality but high morbidity and costs. Our objective was to describe the financial burden of complications following pancreaticoduodenectomy. METHODS: We searched for articles using the MEDLINE, EMBASE, Cochrane and EconLit databases from the year 2000. Additional studies were identified by searching bibliographies. We included studies reporting on hospital cost or charge of in-hospital complications during the index PD admission. Studies including other surgeries but specifically reporting inpatient complication costs of PD were also included. Any type of PD was included. Data was collected using a data extraction table and a narrative synthesis was performed. RESULTS: We identified 15 eligible articles. All included articles were retrospective studies. Acceptable evidence for increased cost due to the presence and grade of complication was found. Strong evidence demonstrated the high rate of complications. Weak evidence linked complications with specific constituents of hospital cost. Complication grade was robustly linked with increased length of stay. Not enough evidence was found to demonstrate a link between PD complications and mortality or readmissions. LIMITATIONS: Included studies were heterogeneous in setting, methodology, costing data, and grading systems. CONCLUSIONS: The presence and grade of PD complications increase hospital cost across diverse settings. The costing methodology should be transparent and complication grading systems should be consistent in future studies. SYSTEMATIC REVIEW REGISTRATION NUMBER: PROSPERO 2017:CRD42017058427.
BACKGROUND/ OBJECTIVES: Pancreaticoduodenectomy (PD), also known as a Whipple procedure, is commonly performed for a variety of benign and malignant tumours, including of the pancreatic head and surrounding structures. PD is associated with low mortality but high morbidity and costs. Our objective was to describe the financial burden of complications following pancreaticoduodenectomy. METHODS: We searched for articles using the MEDLINE, EMBASE, Cochrane and EconLit databases from the year 2000. Additional studies were identified by searching bibliographies. We included studies reporting on hospital cost or charge of in-hospital complications during the index PD admission. Studies including other surgeries but specifically reporting inpatient complication costs of PD were also included. Any type of PD was included. Data was collected using a data extraction table and a narrative synthesis was performed. RESULTS: We identified 15 eligible articles. All included articles were retrospective studies. Acceptable evidence for increased cost due to the presence and grade of complication was found. Strong evidence demonstrated the high rate of complications. Weak evidence linked complications with specific constituents of hospital cost. Complication grade was robustly linked with increased length of stay. Not enough evidence was found to demonstrate a link between PD complications and mortality or readmissions. LIMITATIONS: Included studies were heterogeneous in setting, methodology, costing data, and grading systems. CONCLUSIONS: The presence and grade of PD complications increase hospital cost across diverse settings. The costing methodology should be transparent and complication grading systems should be consistent in future studies. SYSTEMATIC REVIEW REGISTRATION NUMBER: PROSPERO 2017:CRD42017058427.
Authors: J Meyerov; M Louis; D K Lee; L Fletcher; D Banyasz; L F Miles; R Ma; S Tosif; A N Koshy; D A Story; R Bellomo; L Weinberg Journal: BJS Open Date: 2021-03-05
Authors: Clement Marcelin; Auh Whan Park; Patrick Gilbert; Louis Bouchard; Eric Therasse; Pierre Perreault; Marie France Giroux; Gilles Soulez Journal: CVIR Endovasc Date: 2022-01-03
Authors: Ralph J A Linnemann; Bob J L Kooijman; Christian S van der Hilst; Joost Sprakel; Carlijn I Buis; Schelto Kruijff; Joost M Klaase Journal: Cancers (Basel) Date: 2021-12-14 Impact factor: 6.639